Dates:
Closing date: 31 March 2030, 11:59pm (Midnight)
Opening date:
- Round 1 will open for applications on 30 October 2024 and close on 29 November 2024 at 12 PM
- Round 2 will open on 01 February 2024 and close on 28 February 2025 at 12 PM
- Round 3 will open on 01 May 2025 and close on 30 May 2025 at 12 PM
- Round 4 will open on 01 August 2025 and close on 29 August 2025 at 12 PM.
April 2025 – first grants awarded to successful projects.
Scope
The fund will enhance and accelerate affordable access to mature, new and emerging Life Sciences products for both pandemic and non-pandemic scenarios. LSIMF will provide up to £520 million in capital grants for investment in the manufacture of human medicines and medical technology (including diagnostics, and MedTech products).
Specific Themes
To increase UK health resilience by strengthening the UK’s manufacturing capacity and capability. We define health resilience as the UK’s ability to withstand and recover from health emergencies such as pandemics, long-term healthcare challenges and supply chain disruption. To create economic opportunity through investments that will make a substantial contribution to Gross Value Added (GVA) and provide high-wage, high-skilled jobs around the UK.
Projects that will not be funded
Veterinary medicine/ Herbal medicines/ Nutritional supplements or vitamins/ Raw ingredients (e.g solvents, buffers and cleaning agents)/ The production of single-use consumables that are not integrated into a larger product (e.g manufacturing syringes independently from diagnostic kits)/ Secondary packaging for products or materials (e.g package inserts, labelling and boxes).
Eligibility
your company must be: A UK registered company / A wholly private sector business / A product developer, contract development manufacturing organisation, or a generics manufacturer.
your project must:
- Have a total cost (capital and non-capital costs) of at least £8 million
- Be located in the UK
- Be primarily a capital investment
- Be a single company investment (as opposed to forming a partnership between companies or other types of organisations)
- Require only the amount of grant requested to proceed. For example, without the specific amount of funding you are requesting your project wouldn’t go ahead or go ahead at a smaller scale, go ahead overseas or would be significantly delayed (3 years or more)
Funding Rates
Projects with a total cost (including capital expenditure) of at least £8 million are eligible to apply (£520M pot). Our typical intervention rate is between 10-20% of your total project costs. For example, for a project with a total cost of £100m, the typical grant awarded might be £10-20m.
How PNO can support you
The UK team has a strong track record in securing some of the most competitive national and European grants on behalf of its clients, with a full understanding of how a project should be presented to stand the highest chance of success. Each year in the UK alone, we are responsible for the submission of more than 100 funding applications across all sectors and priority areas. Based on this extensive experience, through careful project selection and using key insight into how a project should be best positioned, we consistently achieve success rates that are more than 5 times the typical success rates for UK national schemes and EU programmes.
For further information or to discuss a project idea please contact PNO Consultants
0161 488 3488 | info.uk@pnoconsultants.com
